Dr Stuart Onions

Stuart has over 20 years drug discovery experience. He has held a variety of positions at Sygnature Discovery being promoted to his current position in 2024.  Having benefitted from a broad range of approaches and tactics to deliver optimal preclinical candidates, he is highly-skilled in servicing, influencing and guiding biotechnology companies through the discovery process. Stuart has previously led multiple medicinal chemistry programs delivering five compounds to ongoing clinical trials. More recently, two first-in-class preclinical anti-infectives therapeutic agents have been discovered under his supervision. He is recognised as an inventor on over thirty patents and has authored eleven papers.

Stuart holds a first class medicinal chemistry degree and a Ph.D. in Supra-molecular Chemistry. He also served as a non-executive Director of Peak Proteins, a CRO specialising in the production, supply and crystallisation of proteins.